Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator,PF‐06648671, onCSFAmyloid‐β Peptides in Randomized Phase I Studies-Reference-Cited by-同舟云学术

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator,PF‐06648671, onCSFAmyloid‐β Peptides in Randomized Phase I Studies

Published:2019-09-11 Issue:1 Volume:107 Page:211-220
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Ahn Jae Eun¹,Carrieri Charles¹,Dela Cruz Fernando¹,Fullerton Terence¹,Hajos‐Korcsok Eva¹²,He Ping¹³,Kantaridis Constantino⁴,Leurent Claire¹⁵,Liu Richann¹⁶,Mancuso Jessica¹,Mendes da Costa Laure⁴,Qiu Ruolun¹

Affiliation:

1. Pfizer Inc Cambridge Massachusetts USA

2. Sunovion Pharmaceuticals Marlborough Massachusetts USA

3. Biogen Inc Cambridge Massachusetts USA

4. Brussels CRUPfizer Inc Brussels Belgium

5. Samsung Ventures America Boston Massachusetts USA

6. ICON Boston Massachusetts USA

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1570

Reference40 articles.

1. EFNS guidelines for the diagnosis and management of Alzheimer’s disease

2. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

3. Amyloid deposition as the central event in the aetiology of Alzheimer's disease

4. A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease;Journal of Medicinal Chemistry;2024-06-07

2. Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy;Neurochemical Research;2024-06-06

3. Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?;Diseases;2024-05-22

4. New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of γ-secretases;The EMBO Journal;2024-02-23

5. Review on anti-alzheimer drug development: approaches, challenges and perspectives;RSC Advances;2024